Bath & Body Works (BBWI) Set to Announce Quarterly Earnings on Thursday

Bath & Body Works (NYSE:BBWI) is scheduled to issue its quarterly earnings data before the market opens on Thursday, November 16th. Analysts expect the company to announce earnings of $0.35 per share for the quarter. Investors that wish to listen to the company’s conference call can do so using this link.

Bath & Body Works (NYSE:BBWI) last posted its quarterly earnings data on Wednesday, August 23rd. The company reported $0.40 earnings per share for the quarter, topping the consensus estimate of $0.33 by $0.07. Bath & Body Works had a negative return on equity of 30.08% and a net margin of 9.47%. The business had revenue of $1.56 billion for the quarter, compared to analysts’ expectations of $1.56 billion. During the same quarter in the previous year, the firm earned $0.52 earnings per share. The business’s revenue was down 3.6% on a year-over-year basis. On average, analysts expect Bath & Body Works to post $3 EPS for the current fiscal year and $4 EPS for the next fiscal year.

Bath & Body Works Stock Performance

NYSE:BBWI opened at $31.59 on Thursday. Bath & Body Works has a 52-week low of $27.30 and a 52-week high of $49.55. The firm has a market cap of $7.18 billion, a price-to-earnings ratio of 10.29, a PEG ratio of 1.08 and a beta of 1.84. The business’s fifty day moving average is $32.94 and its 200 day moving average is $35.44.

Bath & Body Works Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, December 1st. Stockholders of record on Friday, November 17th will be issued a $0.20 dividend. This represents a $0.80 dividend on an annualized basis and a dividend yield of 2.53%. The ex-dividend date is Thursday, November 16th. Bath & Body Works’s payout ratio is currently 26.06%.

Hedge Funds Weigh In On Bath & Body Works

Institutional investors have recently modified their holdings of the business. BlackRock Inc. grew its stake in shares of Bath & Body Works by 1.0% during the first quarter. BlackRock Inc. now owns 17,074,153 shares of the company’s stock worth $624,573,000 after purchasing an additional 174,915 shares in the last quarter. State Street Corp lifted its position in Bath & Body Works by 0.6% in the third quarter. State Street Corp now owns 10,038,767 shares of the company’s stock valued at $327,264,000 after acquiring an additional 58,201 shares during the last quarter. Price T Rowe Associates Inc. MD lifted its position in Bath & Body Works by 8.2% in the second quarter. Price T Rowe Associates Inc. MD now owns 6,364,253 shares of the company’s stock valued at $171,326,000 after acquiring an additional 484,674 shares during the last quarter. Geode Capital Management LLC raised its holdings in shares of Bath & Body Works by 2.3% in the first quarter. Geode Capital Management LLC now owns 4,725,145 shares of the company’s stock valued at $172,450,000 after buying an additional 106,263 shares during the last quarter. Finally, Bank of America Corp DE raised its holdings in shares of Bath & Body Works by 23.8% in the first quarter. Bank of America Corp DE now owns 3,696,733 shares of the company’s stock valued at $135,226,000 after buying an additional 709,500 shares during the last quarter. Institutional investors and hedge funds own 94.31% of the company’s stock.

Wall Street Analysts Forecast Growth

BBWI has been the subject of several analyst reports. JPMorgan Chase & Co. cut Bath & Body Works from a “neutral” rating to an “underweight” rating and dropped their target price for the company from $41.00 to $27.00 in a report on Tuesday, October 24th. UBS Group upped their price target on Bath & Body Works from $38.00 to $39.00 and gave the company a “neutral” rating in a research report on Thursday, August 24th. Telsey Advisory Group reaffirmed an “outperform” rating and set a $52.00 price target on shares of Bath & Body Works in a research report on Wednesday, August 23rd. Barclays raised Bath & Body Works from an “equal weight” rating to an “overweight” rating and upped their price target for the company from $41.00 to $45.00 in a research report on Tuesday, August 1st. Finally, Citigroup increased their target price on Bath & Body Works from $38.00 to $40.00 and gave the stock a “neutral” rating in a research report on Wednesday, August 16th. One analyst has rated the stock with a sell rating, seven have assigned a hold rating and seven have given a buy rating to the company. According to MarketBeat, Bath & Body Works presently has a consensus rating of “Hold” and a consensus price target of $44.13.

Bath & Body Works Company Profile

Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. It sells its products under the Bath & Body Works, White Barn, and other brand names through retail stores and e-commerce sites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.